Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$4.95 - $6.6 $96,505 - $128,673
19,496 New
19,496 $98,000
Q1 2021

May 13, 2021

SELL
$10.38 - $15.61 $45,817 - $68,902
-4,414 Reduced 22.69%
15,036 $174,000
Q4 2020

Feb 09, 2021

BUY
$9.28 - $13.88 $35,328 - $52,841
3,807 Added 24.34%
19,450 $221,000
Q3 2020

Nov 12, 2020

BUY
$10.61 - $13.96 $25,410 - $33,434
2,395 Added 18.08%
15,643 $174,000
Q2 2020

Aug 12, 2020

BUY
$10.91 - $18.56 $144,535 - $245,882
13,248 New
13,248 $150,000

Others Institutions Holding LYRA

About Lyra Therapeutics, Inc.


  • Ticker LYRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,826,400
  • Market Cap $5.73M
  • Description
  • Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained...
More about LYRA
Track This Portfolio

Track Bank Of New York Mellon Corp Portfolio

Follow Bank Of New York Mellon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.